Kevin McManus

Kevin McManus has extensive work experience in the biotechnology and clinical research industries. Kevin currently serves as a Scientist III in Analytical Development at Matica Biotechnology, Inc. Since joining the company in November 2022, they have played a key role in the development and analysis of pharmaceutical products.

Prior to their current role, Kevin worked at iBio, Inc. as a Senior Product Characterization Scientist starting from July 2020. In this position, they contributed to the characterization and testing of various products.

Before joining iBio, Kevin was employed at Hyperion Biotechnology as a Scientist specializing in LC-MS/MS from April 2020 to July 2020. During this time, they utilized LC-MS/MS techniques for analyzing and measuring molecules.

From October 2019 to April 2020, Kevin worked as a Senior Development Scientist at Sonic Reference Laboratory. In this role, they conducted research and development activities focused on biochemical assays and diagnostics.

Kevin also has a long tenure at Worldwide Clinical Trials, where they held several positions over their nine-year involvement. Starting from July 2010, they first served as an LC-MS/MS Operations Team Leader and Principal Research Scientist in Bioanalytical Sciences. Kevin later transitioned to become the LC-MS/MS Instrument Operations Team Leader and Principal Research Scientist in Bioanalytical Sciences.

Overall, Kevin McManus has a wealth of experience in analytical development, product characterization, LC-MS/MS analysis, and research and development in the biotechnology and clinical research fields.

Kevin McManus has a Bachelor of Science degree in Biology from the University of Toledo. The specific dates of their education are not mentioned.